ENOV

Enovis Corp

NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES

$24.78

+4.02% today

Updated 2026-06-05

Market cap

$1.25B

P/E ratio

—

P/S ratio

0.55x

EPS (TTM)

$-19.89

Dividend yield

—

52W range

$21 – $37

Volume

1.0M

Market cap

$1.25B

P/E ratio

—

P/S ratio

0.55x

EPS (TTM)

$-19.89

Dividend yield

—

52W range

$21 – $37

Volume

1.0M

Enovis Corp (ENOV) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price

$24.78

12-Month target

—

2030 Target

—

Intrinsic (DCF)

$35.03

Financial forecast

Metric	2021	2022	2023	2024	2025
Revenue	$1.4B	$1.6B	$1.7B	$2.1B	$2.2B
EPS	—	—	—	—	—

CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -49.90%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.